BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  BioMidwest

  Astellas Pharma Exec Shares His Best Life Science Career Advice

  Johnston joined Astellas in 2008 as vice president, marketing and new product planning.

  December 11, 2017

   · 

  4 min read

   · 

  Mark Terry
• 

  Business

  What You Need to Know About Corbin Therapeutics

  Corbin Therapeutics, headquartered in Montreal, Quebec, was spun out of venture capital company AmorChem.

  December 11, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Deals

  Seattle’s PhaseRx Files for Bankruptcy as it Considers Partner, Merger or Sale Options

  The company indicates it plans to continue to manage and operate under the bankruptcy filing while it works with Cowen and Company to develop a plan forward.

  December 11, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Genetown

  3 Biotechs With Critical Product Launches in 2018

  Biotech companies have a number of pivotal challenges in going from a promising compound to commercially viable products.

  December 11, 2017

   · 

  4 min read

   · 

  Mark Terry
• 

  Policy

  Tax Reform: A War on Life Sciences Innovation

  One of the biggest concerns has been the loss of the R&D tax credit, which incentivizes companies, including life science firms, to support research.

  December 11, 2017

   · 

  2 min read

   · 

  Josh Baxt, BioSpace Contributor
• Deals

  Medtronic Takes Out Crospon in $45M Deal

  Medtronic confirmed that it bought Crospon but declined to disclose the value of the deal.

  December 11, 2017

   · 

  1 min read
• 

  Business

  What You Need to Know About Hyalex Orthopaedics

  Hyalex Orthopaedics launched in May 2017 as a medical device company that intends to advance new products featuring HYALEX technology, a synthetic polymer that mimics cartilage.

  December 11, 2017

   · 

  2 min read

   · 

  Mark Terry
• Drug Development

  Seattle Genetics Receives FDA Breakthrough Therapy Designation for ADCETRIS (Brentuximab Vedotin) in Frontline Advanced Hodgkin Lymphoma

  Seattle Genetics today announced that the FDA has granted Breakthrough Therapy Designation to ADCETRIS in combination with chemotherapy for the frontline treatment of patients with advanced classical Hodgkin lymphoma.

  December 11, 2017

   · 

  15 min read
• Drug Development

  Intellia Therapeutics Announces New, Robust Genome Editing Data for Sickle Cell Disease at the American Society of Hematology Meeting

  Data on ex vivo CRISPR/Cas9 genome-edited human hematopoietic stem cells shows increased production of fetal hemoglobin.

  December 11, 2017

   · 

  6 min read
• Drug Development

  Anavex Life Sciences Reports Fiscal 2017 Financial Results And Provides Update On Therapeutic Programs

  The Company also provided an update on its most advanced programs for ANAVEX®2-73 for the treatment of Rett syndrome (RTT).

  December 11, 2017

   · 

  9 min read